$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Use of Engineered Exosomes Expressing HLA and Costimulatory Molecules to Generate Antigen-specific CD8+ T Cells for Adoptive Cell Therapy

Journal of immunotherapy, v.40 no.3, 2017년, pp.83 - 93  

Kim, Sueon (*Catholic Hematopoietic Stem Cell Bank ‡Cancer Research Institute †Departments of Microbiology, College of Medicine, The Catholic University of Korea, Seoul, Korea) ,  Sohn, Hyun-Jung ,  Lee, Hyun-Joo ,  Sohn, Dae-Hee ,  Hyun, Seung-Joo ,  Cho, Hyun-Il ,  Kim, Tai-Gyu

Abstract AI-Helper 아이콘AI-Helper

Dendritic cell-derived exosomes (DEX) comprise an efficient stimulator of T cells. However, the production of sufficient DEX remains a barrier to their broad applicability in immunotherapeutic approaches. In previous studies, genetically engineered K562 have been used to generate artificial antigen ...

Abstract

Dendritic cell-derived exosomes (DEX) comprise an efficient stimulator of T cells. However, the production of sufficient DEX remains a barrier to their broad applicability in immunotherapeutic approaches. In previous studies, genetically engineered K562 have been used to generate artificial antigen presenting cells (AAPC). Here, we isolated exosomes from K562 cells (referred to as CoEX-A2s) engineered to express human leukocyte antigen (HLA)-A2 and costimulatory molecules such as CD80, CD83, and 41BBL. CoEX-A2s were capable of stimulating antigen-specific CD8 T cells both directly and indirectly via CoEX-A2 cross-dressed cells. Notably, CoEX-A2s also generated similar levels of HCMV pp65-specific and MART1-specific CD8 T cells as DEX in vitro. The results suggest that these novel exosomes may provide a crucial reagent for generating antigen-specific CD8 T cells for adoptive cell therapies against viral infection and tumors.

참고문헌 (32)

  1. J Immunol Schuler-Thurner 165 3492 2000 10.4049/jimmunol.165.6.3492 Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1+ melanoma patients by mature monocyte-derived dendritic cells 

  2. J Exp Med Schuler-Thurner 195 1279 2002 10.1084/jem.20012100 Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells 

  3. Traffic Kleijmeer 2 124 2001 10.1034/j.1600-0854.2001.020207.x Antigen loading of MHC class I molecules in the endocytic tract 

  4. J Exp Med Raposo 183 1161 1996 10.1084/jem.183.3.1161 B lymphocytes secrete antigen-presenting vesicles 

  5. Nature Med Zitvogel 4 594 1998 10.1038/nm0598-594 Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes 

  6. Nat Rev Immunol Robbins 14 195 2014 10.1038/nri3622 Regulation of immune responses by extracellular vesicles 

  7. Int Immunol Vincent-Schneider 14 713 2002 10.1093/intimm/dxf048 Exosomes bearing HLA-DR1 molecules need dendritic cells to efficiently stimulate specific T cells 

  8. Nat Immunol Thery 3 1156 2002 10.1038/ni854 Indirect activation of naive CD4+ T cells by dendritic cell-derived exosomes 

  9. J Immunol Montecalvo 180 3081 2008 10.4049/jimmunol.180.5.3081 Exosomes as a short-range mechanism to spread alloantigen between dendritic cells during T cell allorecognition 

  10. J Immunol Methods Curtsinger 209 47 1997 10.1016/S0022-1759(97)00146-4 Artificial cell surface constructs for studying receptor-ligand contributions to lymphocyte activation 

  11. Cancer Lett Lu 271 129 2008 10.1016/j.canlet.2008.05.049 Adoptive transfer of pTRP2-specific CTLs expanding by bead-based artificial antigen-presenting cells mediates anti-melanoma response 

  12. Blood Schilbach 106 144 2005 10.1182/blood-2004-07-2940 Cytotoxic minor histocompatibility antigen HA-1-specific CD8+ effector memory T cells: artificial APCs pave the way for clinical application by potent primary in vitro induction 

  13. Clin Immunol Laux 96 187 2000 10.1006/clim.2000.4902 Response differences between human CD4(+) and CD8(+) T-cells during CD28 costimulation: implications for immune cell-based therapies and studies related to the expansion of double-positive T-cells during aging 

  14. J Immunol Zhang 179 4910 2007 10.4049/jimmunol.179.7.4910 4-1BB is superior to CD28 costimulation for generating CD8+ cytotoxic lymphocytes for adoptive immunotherapy 

  15. Proc Natl Acad Sci USA Derdak 103 13144 2006 10.1073/pnas.0602283103 Direct stimulation of T lymphocytes by immunosomes: virus-like particles decorated with T cell receptor/CD3 ligands plus costimulatory molecules 

  16. Immunol Res Paulos 42 182 2008 10.1007/s12026-008-8070-9 Adoptive immunotherapy: good habits instilled at youth have long-term benefits 

  17. Nat Biotechnol Kim 22 403 2004 10.1038/nbt955 The ABCs of artificial antigen presentation 

  18. Mol Ther Suhoski 15 981 2007 10.1038/mt.sj.6300134 Engineering artificial antigen-presenting cells to express a diverse array of co-stimulatory molecules 

  19. Clin Cancer Res Hirano 12 2967 2006 10.1158/1078-0432.CCR-05-2791 Efficient presentation of naturally processed HLA class I peptides by artificial antigen-presenting cells for the generation of effective antitumor responses 

  20. Clin Cancer Res Butler 13 1857 2007 10.1158/1078-0432.CCR-06-1905 Long-lived antitumor CD8+ lymphocytes for adoptive therapy generated using an artificial antigen-presenting cell 

  21. Curr Opin Cell Biol Simons 21 575 2009 10.1016/j.ceb.2009.03.007 Exosomes-vesicular carriers for intercellular communication 

  22. Haematologica Zappasodi 93 1523 2008 10.3324/haematol.12521 The effect of artificial antigen-presenting cells with preclustered anti-CD28/-CD3/-LFA-1 monoclonal antibodies on the induction of ex vivo expansion of functional human antitumor T cells 

  23. Vaccine Kim 26 3987 2008 10.1016/j.vaccine.2008.05.036 Efficient generation of survivin-specific cytotoxic T lymphocytes from healthy persons in vitro: quantitative and qualitative effects of CD4+ T cells 

  24. J Immunol Thery 166 7309 2001 10.4049/jimmunol.166.12.7309 Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles 

  25. Nat Protoc El-Andaloussi 7 2112 2012 10.1038/nprot.2012.131 Exosome-mediated delivery of siRNA in vitro and in vivo 

  26. Blood Hirano 107 1528 2006 10.1182/blood-2005-05-2073 Engagement of CD83 ligand induces prolonged expansion of CD8+ T cells and preferential enrichment for antigen specificity 

  27. J Leukoc Biol Cho 99 521 2016 10.1189/jlb.1HI0814-409RR Triple costimulation via CD80, 4-1BB, and CD83 ligand elicits the long-term growth of Vgamma9Vdelta2 T cells in low levels of IL-2 

  28. Proc Natl Acad Sci USA Aung 108 15336 2011 10.1073/pnas.1102855108 Exosomal evasion of humoral immunotherapy in aggressive B-cell lymphoma modulated by ATP-binding cassette transporter A3 

  29. Blood Cells Mol Dis Segura 35 89 2005 10.1016/j.bcmd.2005.05.003 Mature dendritic cells secrete exosomes with strong ability to induce antigen-specific effector immune responses 

  30. J Immunol Methods Britten 259 95 2002 10.1016/S0022-1759(01)00499-9 The use of HLA-A*0201-transfected K562 as standard antigen-presenting cells for CD8(+) T lymphocytes in IFN-gamma ELISPOT assays 

  31. Proc Natl Acad Sci USA Hwang 100 6670 2003 10.1073/pnas.1131852100 Direct stimulation of naive T cells by membrane vesicles from antigen-presenting cells: distinct roles for CD54 and B7 molecules 

  32. Blood Segura 106 216 2005 10.1182/blood-2005-01-0220 ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming 

LOADING...
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로